Drug Trial Radar · NCT06052293
Phase 1 Study to Assess Safety and Efficacy of ANG003
Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
57
Actual
Start
Aug 25, 2023
Primary completion
Jul 8, 2024
Study completion Jul 8, 2024
Sponsor
- Lead sponsor
- Anagram Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 25, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomized, parallel, active-treatment Phase 1 study of a single dose of orally administered ANG003 with a test meal in adult subjects with cystic fibrosis-related exocrine pancreatic insufficiency. The study's overall objectives are to evaluate the safety, tolerability and effect of four dose levels of ANG003.
Conditions
- Exocrine Pancreatic Insufficiency
Interventions
ANG003Drug
To evaluate four possible combinations of lipase, protease and amylase.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AE), Serious Adverse Events (SAE) and AEs Leading to Study DiscontinuationTime frame: Assessed through study completion, up to 9 days (Day 1 thru Day 9).
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Long Beach Memorial Medical Center
Long Beach, California
National Jewish Health
Denver, Colorado
Norton Children's Research Institute affiliated with University of Louisville School of Medicine
Louisville, Kentucky
Massachusetts General Hospital,
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
University of Michigan Medical Center
Ann Arbor, Michigan
Harper University Hospital / Wayne State University
Detroit, Michigan
University of Minnesota
Minneapolis, Minnesota
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
Albany Medical College
Albany, New York
New York Medical College at Westchester Medical Center
Valhalla, New York
Akron Childrens Hospital
Akron, Ohio
University of Cincinnati
Cincinnati, Ohio
University Hospitals of Cleveland Medical Center
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
University of Utah
Salt Lake City, Utah
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.